References
- Ravish HS, Srikanth J, Narayana DH, Annadani R, Vijayashankar V, Undi M. Pre-exposure prophylaxis against rabies in children: Safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route. Hum Vaccin Immunother 2013; 9:1910 - 3; http://dx.doi.org/10.4161/hv.25203; PMID: 23787889
- Tenzin, Dhand NK, Ward MP. Human rabies post exposure prophylaxis in Bhutan, 2005-2008: trends and risk factors. Vaccine 2011; 29:4094 - 101; http://dx.doi.org/10.1016/j.vaccine.2011.03.106; PMID: 21497633
- Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, et al, Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC). Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57:RR-3 1 - 28; PMID: 18496505
- WHO Expert Consultation on Rabies. First Report. Geneva: World Health Organization, 2005, (WHO technical report series; 931).
- Lowe ES, Balis FM. Dose-Effect and Concentration-Effect Analysis. In: Atkinson AJ, Daniels CE, Dedrick RL, Grudzinskas CV, Markey SP, editors. Principles of clinical pharmacology. 2nd ed. Burlington: Academic Press; 2006;296-7.
- Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 1998; 72:3711 - 9; PMID: 9557653